These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 6379258
21. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
22. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028 [Abstract] [Full Text] [Related]
23. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM, Bakare NA, Onadeko BO. Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469 [Abstract] [Full Text] [Related]
25. [Short-term chemotherapy of tuberculosis. Cooperative French trial]. Pretet S. Rev Fr Mal Respir; 1983 Mar; 11(6):859-66. PubMed ID: 6366945 [Abstract] [Full Text] [Related]
26. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H. Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [Abstract] [Full Text] [Related]
27. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association. Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175 [Abstract] [Full Text] [Related]
29. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet; 1975 Jan 18; 1(7899):119-24. PubMed ID: 46047 [Abstract] [Full Text] [Related]
30. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Teo SK. Int J Tuberc Lung Dis; 1999 Feb 18; 3(2):126-32. PubMed ID: 10091877 [Abstract] [Full Text] [Related]
31. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens]. Ganguin HG, Cramer G, Götz J, Holzhauer H, Niegsch G, Sieler H, Velten G, Völker L. Z Erkr Atmungsorgane Folia Bronchol; 1973 Feb 18; 138(1):107-15. PubMed ID: 4203235 [No Abstract] [Full Text] [Related]
32. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment]. Kobashi Y, Oka M. Kekkaku; 2008 Dec 18; 83(12):779-84. PubMed ID: 19172823 [Abstract] [Full Text] [Related]
33. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis]. Chu N, Yan B, Zhu L. Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul 18; 21(7):388-91. PubMed ID: 11326873 [Abstract] [Full Text] [Related]
34. [Actual condition and chemotherapy of extrapulmonary tuberculosis in national sanatoria. (An observation in intestinal tuberculosis and tuberculous peritonitis)--report of the B series of 26th controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)]. Konishiike J, Unno M, Yamamoto S. Kekkaku; 1986 Apr 18; 61(4):243-52. PubMed ID: 3525960 [No Abstract] [Full Text] [Related]
35. [Clinical efficacy of intermittent chemotherapy with initial intensive regimen in original treatment for pulmonary tuberculosis. Report of the 18th series of controlled trial of chemotherapy (author's transl)]. Kekkaku; 1977 Jul 18; 52(7):345-51. PubMed ID: 909221 [No Abstract] [Full Text] [Related]
36. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct 18; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
37. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet; 1972 May 20; 1(7760):1079-85. PubMed ID: 4112569 [No Abstract] [Full Text] [Related]
38. A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore. Am Rev Respir Dis; 1986 Jul 20; 134(1):27-33. PubMed ID: 3524334 [Abstract] [Full Text] [Related]
39. [A short course of chemotherapy in newly diagnosed and retreatment of smear-positive pulmonary tuberculosis in a rural area]. Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug 20; 12(4):220-2, 254-5. PubMed ID: 2636947 [Abstract] [Full Text] [Related]
40. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report. Balasubramanian R, Nagarajan M, Balambal R, Tripathy SP, Sundararaman R, Venkatesan P, Paramasivam CN, Rajasambandam P, Rangabashyam N, Prabhakar R. Int J Tuberc Lung Dis; 1997 Feb 20; 1(1):44-51. PubMed ID: 9441058 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]